Location History:
- Yokohama, JP (2020)
- Shinagawa, JP (2023 - 2024)
Company Filing History:
Years Active: 2020-2024
Title: Emi Nozaki: Innovator in Lipid Particle Technology
Introduction
Emi Nozaki is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of lipid particle technology, focusing on methods for delivering activators to cells. With a total of 3 patents to his name, Nozaki's work is paving the way for advancements in pharmaceutical compositions.
Latest Patents
Nozaki's latest patents include innovative formulations that utilize lipid particles for effective drug delivery. One of his notable inventions is a compound represented by the formula (1): Q-CHR, where Q is a nitrogen-containing aliphatic group with two or more tertiary nitrogens and R is an aliphatic group containing a biodegradable group. This compound, when combined with other lipids, can form lipid particles that are capable of reducing aggregation. These lipid particles can be utilized in pharmaceutical compositions to deliver activators into cells, showcasing the potential for significant medical applications.
Career Highlights
Emi Nozaki is associated with Kabushiki Kaisha Toshiba, where he continues to innovate and develop new technologies. His work has garnered attention for its potential impact on drug delivery systems, making him a key figure in the field of biopharmaceuticals.
Collaborations
Nozaki collaborates with talented individuals such as Mitsuko Ishihara and Eiichi Akahoshi, contributing to a dynamic research environment that fosters innovation and creativity.
Conclusion
Emi Nozaki's contributions to lipid particle technology and drug delivery systems highlight his role as a leading inventor in the field. His innovative patents and collaborations are set to influence the future of pharmaceutical compositions significantly.